Personalised molecular medicine possible in muscular dystrophy?

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1620, 2008-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalised medicine with genetic-guided warfarin dosing?

By  

Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Personalised medicines, according to genotype?

By  

Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Personalised Genetic Intervention for Duchenne Muscular Dystrophy: Antisense Oligomers and Exon Skipping

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 110-121

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular pathophysiology and targeted therapeutics for muscular dystrophy

By Hoffman E.P.   Dressman D.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 9, 2001-09 ,pp. : 465-470

Elsevier

Access to resources Recommend Favorite

Control of MRSA possible?

By  

Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite